Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.

Ahmad Kiadaliri, Aliasghar LU orcid ; Gerdtham, Ulf LU orcid ; Eliasson, Bjorn and Steen Carlsson, Katarina LU orcid (2014) In Diabetes therapy : research, treatment and education of diabetes and related disorders 5(2). p.591-607
Abstract
This study aimed to assess the costs and benefits of three alternative second-line treatment strategies for Swedish patients with type 2 diabetes mellitus (T2DM) who fail to reach glycated hemoglobin (HbA1c) ≤ 7% with metformin treatment alone: glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and neutral protamine Hagedorn (NPH) insulin.
Please use this url to cite or link to this publication:
author
; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
in
Diabetes therapy : research, treatment and education of diabetes and related disorders
volume
5
issue
2
pages
591 - 607
publisher
Springer
external identifiers
  • pmid:25213800
  • scopus:84919617689
  • pmid:25213800
  • wos:000209718400019
ISSN
1869-6953
DOI
10.1007/s13300-014-0080-0
language
English
LU publication?
yes
id
bfa68c70-de5f-4f5f-a765-7e7d34ec5ab2 (old id 4691822)
alternative location
http://www.ncbi.nlm.nih.gov/pubmed/25213800?dopt=Abstract
date added to LUP
2016-04-01 13:31:42
date last changed
2023-10-01 03:02:10
@article{bfa68c70-de5f-4f5f-a765-7e7d34ec5ab2,
  abstract     = {{This study aimed to assess the costs and benefits of three alternative second-line treatment strategies for Swedish patients with type 2 diabetes mellitus (T2DM) who fail to reach glycated hemoglobin (HbA1c) ≤ 7% with metformin treatment alone: glucagon-like peptide-1 (GLP-1) receptor agonists, dipeptidyl peptidase-4 (DPP-4) inhibitors, and neutral protamine Hagedorn (NPH) insulin.}},
  author       = {{Ahmad Kiadaliri, Aliasghar and Gerdtham, Ulf and Eliasson, Bjorn and Steen Carlsson, Katarina}},
  issn         = {{1869-6953}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{591--607}},
  publisher    = {{Springer}},
  series       = {{Diabetes therapy : research, treatment and education of diabetes and related disorders}},
  title        = {{Cost-Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden.}},
  url          = {{https://lup.lub.lu.se/search/files/3431348/5277028}},
  doi          = {{10.1007/s13300-014-0080-0}},
  volume       = {{5}},
  year         = {{2014}},
}